Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE

By sjmartinez • January 22, 2025

Grinspoon SK, Zanni MV, Triant VA, Kantor A, Umbleja T, Diggs MR, Chu SM, Fitch KV, Currier JS, Bloomfield GS, Casado JL, de la Peña M, Fantry LE, Gardner E, Aberg JA, Malvestutto CD, Fichtenbaum CJ, Lu MT, Ribaudo HJ, Douglas PS. Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE. Lancet HIV. 2025 Jan 17:S2352-3018(24)00276-5. doi: 10.1016/S2352-3018(24)00276-5. Epub ahead of print. PMID: 39832519.

Tags: Infectious Diseases, Publications

Correction: Empowering Women’s PrEP Choices: Qualitative Insights into Long-Acting PrEP Preferences and Decision-Making during Pregnancy and Breastfeeding in South Africa and Botswana

Chen-Charles J, De Vos L, Vundhla P, Gebengu A, Rousseau E, Bekker LG, Peters R, Mussa A, Morroni C, Toska E, Babalola CM, Klausner JD,[...]

Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS

Costa Monteiro AC, Pickering H, Sarma A, Taylor CS, Jenkins MM, Hsu FM, Nadel B, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA,[...]

Ebola virus in Kasai revives 50-year-old questions on viral latency

Bryan ME, Nzanzu Vivalya BM, Geisbert TW, Judson SD, Munster V. Ebola virus in Kasai revives 50-year-old questions on viral latency. Lancet. 2025 Oct 10:S0140-6736(25)01973-7.[...]